Insider Trading & Ownership - Allogene Therapeutics Inc. (ALLO)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Allogene Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-30
Purchase
2024-03-06
9:52 pm
Allogene Therapeutics Inc.ALLOParker Geoffrey M.
CHIEF FINANCIAL OFFICER
190$3.595$683819,590
(Direct)
View
2023-12-18
Sale
2023-12-20
4:26 pm
Allogene Therapeutics Inc.ALLOMESSEMER DEBORAH M.
Director
18,640$2.6994$50,31762,456
(Direct)
View
2023-08-07
Sale
2023-08-09
4:07 pm
Allogene Therapeutics Inc.ALLOMayo Stephen
Director
10,000$4.2855$42,85525,328
(Direct)
View
2023-02-13
Sale
2023-02-14
5:10 pm
Allogene Therapeutics Inc.ALLOBhavnagri Veer
General Counsel
3,000$6.85$20,550577,677
(Direct)
View
2023-01-17
Sale
2023-01-18
6:10 pm
Allogene Therapeutics Inc.ALLOBhavnagri Veer
General Counsel
3,000$7.04$21,120580,677
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-14
Tax Withholding
2024-03-18
8:10 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOChang David D
President and CEO
53,393$4.337,378,474
(Direct)
View
2024-01-25
Option Award
2024-01-31
5:51 pm
N/A
2034-01-25
Allogene Therapeutics Inc.ALLOMOORE TIMOTHY L.
Chief Technical Officer
438,115$0624,334
(Direct)
View
2024-01-25
Option Award
2024-01-31
5:48 pm
N/A
2034-01-25
Allogene Therapeutics Inc.ALLODouglas Earl Martin
SVP, General Counsel
189,578$0625,412
(Direct)
View
2024-01-25
Option Award
2024-01-31
5:47 pm
N/A
2034-01-25
Allogene Therapeutics Inc.ALLOParker Geoffrey M.
CHIEF FINANCIAL OFFICER
133,339$0923,339
(Direct)
View
2024-01-25
Option Award
2024-01-31
5:46 pm
N/A
2034-01-25
Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director
961,371$09,319,579
(Direct)
View
2024-01-25
Option Award
2024-01-31
5:45 pm
N/A
2034-01-25
Allogene Therapeutics Inc.ALLORoberts Zachary
EVP of R&D
634,949$01,010,202
(Direct)
View
2024-01-25
Option Award
2024-01-31
5:42 pm
N/A
2034-01-25
Allogene Therapeutics Inc.ALLOChang David D
President and CEO
1,441,335$08,549,934
(Direct)
View
2024-01-22
Tax Withholding
2024-01-24
5:25 pm
N/A
N/A
Allogene Therapeutics Inc.ALLORoberts Zachary
EVP of R&D
24,690$3.1744375,253
(Direct)
View
2023-10-16
Option Award
2023-10-17
5:02 pm
N/A
2033-10-16
Allogene Therapeutics Inc.ALLOParker Geoffrey M.
CHIEF FINANCIAL OFFICER
1,740,000$01,740,000
(Direct)
View
2023-08-14
Option Award
2023-08-17
6:57 pm
N/A
2033-08-14
Allogene Therapeutics Inc.ALLODouglas Earl Martin
GENERAL COUNSEL
1,396,688$01,396,688
(Direct)
View
2023-08-10
Option Award
2023-08-14
7:59 pm
N/A
2033-08-10
Allogene Therapeutics Inc.ALLOCHEN YINLIN JACK
SVP, Finance
50,561$0128,041
(Direct)
View

Ownership
2023-08-14
7:28 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOCHEN YINLIN JACK
SVP, Finance
0$0272,725
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:06 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOMESSEMER DEBORAH M.
Director
74,561$081,096
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:03 pm
N/A
2033-06-13
Allogene Therapeutics Inc.ALLOBarrett Elizabeth A.
Director
116,120$0116,120
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:02 pm
N/A
2033-06-13
Allogene Therapeutics Inc.ALLOSATO VICKI L
Director
82,873$0124,324
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:01 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOHumer Franz B
Director
74,561$0266,453
(Direct)
View
2023-06-13
Option Award
2023-06-15
5:00 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOWITTE OWEN N.
Director
74,561$0292,832
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:57 pm
N/A
2033-06-13
Allogene Therapeutics Inc.ALLOMayo Stephen
Director
116,120$0116,120
(Direct)
View
2023-06-13
Option Award
2023-06-15
4:56 pm
N/A
2033-06-13
Allogene Therapeutics Inc.ALLOKazam Joshua A
Director
116,120$0116,120
(Direct)
View
2023-04-24
Option Award
2023-04-26
5:20 pm
N/A
2033-04-24
Allogene Therapeutics Inc.ALLOMOORE TIMOTHY L.
Chief Technical Officer
1,017,243$01,017,243
(Direct)
View
2023-04-03
Option Award
2023-04-05
6:43 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOSmith Lillian
VP, Corporate Counsel
56,545$0140,390
(Direct)
View

Ownership
2023-04-05
6:38 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOSmith Lillian
VP, Corporate Counsel
0$0229,674
(Direct)
View
2023-03-22
Option Award
2023-03-24
8:19 pm
N/A
2033-03-22
Allogene Therapeutics Inc.ALLOMOORE ALISON
Chief Technical Officer
990,832$01,105,469
(Direct)
View
2023-03-22
Option Award
2023-03-24
8:17 pm
N/A
2033-03-22
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
990,832$02,447,772
(Direct)
View
2023-03-22
Option Award
2023-03-24
8:16 pm
N/A
N/A
Allogene Therapeutics Inc.ALLORoberts Zachary
EVP of R&D
148,035$0399,943
(Direct)
View
2023-03-22
Option Award
2023-03-24
8:14 pm
N/A
2033-03-22
Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director
2,277,776$09,353,008
(Direct)
View
2023-03-22
Option Award
2023-03-24
8:13 pm
N/A
2033-03-22
Allogene Therapeutics Inc.ALLOChang David D
President and CEO
3,416,664$08,599,307
(Direct)
View
2023-03-14
Tax Withholding
2023-03-16
5:32 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOChang David D
President and CEO
22,340$5.565,182,643
(Direct)
View
2023-03-14
Tax Withholding
2023-03-16
5:08 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOSCHMIDT ERIC THOMAS
Chief Financial Officer
35,879$5.471,456,940
(Direct)
View
2023-03-14
Tax Withholding
2023-03-16
4:49 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOMOORE ALISON
Chief Technical Officer
8,351$5.5071114,637
(Direct)
View
2023-03-14
Tax Withholding
2023-03-16
4:46 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOBhavnagri Veer
General Counsel
23,628$5.67556,049
(Direct)
View
2023-01-20
Option Award
2023-01-24
5:02 pm
N/A
2033-01-20
Allogene Therapeutics Inc.ALLORoberts Zachary
EVP of R&D
1,124,923$01,124,923
(Direct)
View
Goto 0, 1, 2, 3, 4, Next